Literature DB >> 10620630

Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer.

S P Shriver1, H A Bourdeau, C T Gubish, D L Tirpak, A L Davis, J D Luketich, J M Siegfried.   

Abstract

BACKGROUND: Activation of gastrin-releasing peptide receptor (GRPR) in human airways has been associated with a proliferative response of bronchial cells to gastrin-releasing peptide and with long-term tobacco use. The GRPR gene is located on the X chromosome and escapes X-chromosome inactivation, which occurs in females. Increasing evidence demonstrates that women are more susceptible than men to tobacco carcinogenesis. We hypothesized that the susceptibility of women to the effects of tobacco may be associated with airway expression of GRPR.
METHODS: We analyzed GRPR messenger RNA (mRNA) expression in lung tissues and cultured airway cells from 78 individuals (40 males and 38 females) and in lung fibroblasts exposed to nicotine in vitro. Nicotinic acetylcholine receptors in airway cells were assayed by use of radioactively labeled nicotine and nicotine antagonists. A polymorphism in exon 2 of the GRPR gene was used to detect allele-specific GRPR mRNA expression in some individuals. Statistical tests were two-sided.
RESULTS: GRPR mRNA expression was detected in airway cells and tissues of more female than male nonsmokers (55% versus 0%) and short-term smokers (1-25 pack-years [pack-years = number of packs of cigarettes smoked per day multiplied by the number of years of smoking]) (75% versus 20%) (P =.018 for nonsmoking and short-term smoking females versus nonsmoking and short-term smoking males). Female smokers exhibited expression of GRPR mRNA at a lower mean pack-year exposure than male smokers (37.4 pack-years versus 56.3 pack-years; P =.037). Lung fibroblasts and bronchial epithelial cells exhibited high-affinity, saturable nicotinic acetylcholine-binding sites. Expression of GRPR mRNA in lung fibroblasts was elevated following exposure to nicotine.
CONCLUSIONS: Our results suggest that the GRPR gene is expressed more frequently in women than in men in the absence of smoking and that expression of this gene is activated earlier in women in response to tobacco exposure. The presence of two expressed copies of the GRPR gene in females may be a factor in the increased susceptibility of women to tobacco-induced lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620630     DOI: 10.1093/jnci/92.1.24

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  31 in total

Review 1.  Molecular genetic abnormalities in the pathogenesis of human lung cancer.

Authors:  E Forgacs; S Zöchbauer-Müller; E Oláh; J D Minna
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

Review 3.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

4.  Gender differences in pulmonary regenerative response to naphthalene-induced bronchiolar epithelial cell injury.

Authors:  J R Oliver; R Kushwah; J Wu; E Cutz; H Yeger; T K Waddell; J Hu
Journal:  Cell Prolif       Date:  2009-07-09       Impact factor: 6.831

5.  Augmented Responses to Ozone in Obese Mice Require IL-17A and Gastrin-Releasing Peptide.

Authors:  Joel A Mathews; Nandini Krishnamoorthy; David I Kasahara; John Hutchinson; Youngji Cho; Jeffrey D Brand; Alison S Williams; Allison P Wurmbrand; Luiza Ribeiro; Frank Cuttitta; Mary E Sunday; Bruce D Levy; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2018-03       Impact factor: 6.914

Review 6.  Lung cancer in women.

Authors:  Raúl Barrera-Rodriguez; Jorge Morales-Fuentes
Journal:  Lung Cancer (Auckl)       Date:  2012-12-15

7.  Elevated gastrin-releasing peptide receptor mRNA expression in buccal mucosa: association with head and neck squamous cell carcinoma.

Authors:  Ann Marie Egloff; Xuwan Liu; Autumn L Gaither Davis; Brian K Trevelline; Marike Vuga; Jill M Siegfried; Jennifer R Grandis
Journal:  Head Neck       Date:  2012-03-20       Impact factor: 3.147

Review 8.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

9.  Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Authors:  Anne M Traynor; Joan H Schiller; Laura P Stabile; Jill M Kolesar; Jens C Eickhoff; Sanja Dacic; Tien Hoang; Sarita Dubey; Sarah M Marcotte; Jill M Siegfried
Journal:  Lung Cancer       Date:  2008-08-12       Impact factor: 5.705

Review 10.  Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

Authors:  Mudit Vaid; Joanna Floros
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.